Project Grant R21AG088756
Award Date
9/15/24
Completion Date
8/31/26
Dollars Obligated
$424K
Federal Agency
National Institute on Aging
Federal Grant Program
93.866
Assistance Type
Project Grant
Place of Performance
Lexington, KY 40526, USA
Similar Awards
This federal Project Grant award, provided by the National Institutes of Health's National Institute on Aging under CFDA Program 93.866 - Aging Research, aims to determine the mechanism responsible for tau-induced blood-brain barrier dysfunction and tau transport in Alzheimer's disease (AD), and develop a therapeutic intervention to repair amyloid-beta (Aβ) and tau-induced barrier dysfunction. The $758,744 award to the University of Kentucky Research Foundation, with a performance period from...
This National Institute on Aging (NIA) Project Grant award under the Aging Research federal grant program (CFDA 93.866) will support research to investigate the role of mitochondrial dysfunction in the development of Alzheimer's disease-like pathology following traumatic brain injury (TBI). The $158,247 award, covering the period from August 1, 2024 to July 31, 2027, will fund a project at the University of Cincinnati that aims to characterize cell-specific changes in mitochondrial bioenergetics...
This federal Project Grant award, funded by the National Institute on Aging (CFDA 93.866 - Aging Research), aims to investigate the mechanisms of traumatic brain injury (TBI)-induced vascular and neuronal dysfunction. The $192,737 award, granted to Texas Tech University Health Sciences Center, will support research to determine whether inhibiting the interaction between prostaglandins and the protein UCHL1 can mitigate TBI-induced blood-brain barrier disruption, chondroitin sulfate...
This federal Project Grant award, totaling $2,283,334, was provided by the National Institute on Aging (NIA) under the Aging Research program (CFDA 93.866). The award was granted to the Morehouse School of Medicine (MSM) to develop and validate a progressive murine model for traumatic brain injury (TBI)-induced Alzheimer's disease and related dementias (TBI-ADRD). The key objectives of this 5-year project are to: 1) Screen diverse mouse strains and TBI injury models to identify the optimal...
This federal Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) provides $3,109,079 to the Regents of the University of California at Riverside to model the role of age at traumatic brain injury (TBI) in the development of Alzheimer's disease and related dementias (ADRD). The research aims to examine how ADRD risk factors like APOE and amyloid-beta accelerate ADRD progression in a closed head injury TBI mouse model over the animal's lifespan. The study will...
This Project Grant award, provided by the National Institute on Aging (CFDA 93.866 - Aging Research), aims to develop novel gyrencephalic animal models that can recapitulate the complex neuropathological and clinical features associated with traumatic brain injury (TBI)-induced Alzheimer's disease and related dementias (ADRD). The $3,102,638.00 award, with a period of performance from August 15, 2024 to July 31, 2027, will support research conducted by the University of Pennsylvania to create...
This Project Grant award from the National Institute on Aging's Aging Research Federal Grant Program (CFDA 93.866) provides $1,012,534 to Eydis Bio, Inc. to develop orally bioavailable and blood-brain barrier penetrant, small molecule TAK1 inhibitors as a novel treatment for Alzheimer's disease. The award aims to identify suitable TAK1 inhibitors with optimal central nervous system penetrance that can be advanced into in vivo testing in the PS19 mouse model. The project builds on Eydis Bio's...
This federal Project Grant award from the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program provides $954,307.97 to The University of Kentucky Research Foundation to conduct research on "REPURPOSING EBSELEN FOR TBI-INDUCED PSR ACTIVATION IN TAUOPATHIES AND ALZHEIMER'S DISEASE". The research aims to explore innovative approaches to the prevention, diagnosis, and treatment of neurological conditions relevant to military personnel and...
This Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) provides $1,592,854 to the University of Illinois to conduct research on tau protein conformation and its role in neurodegenerative diseases like Alzheimer's. The central hypothesis is that pathogenic forms of tau represent misregulation of normal tau functions as a scaffold for signaling pathways. The 2-year project aims to define the effects of tau post-translational modifications on tau function and...
This $3,770,822 federal Project Grant award from the National Institute on Aging's Aging Research program (CFDA 93.866) supports a research project at the University of Pittsburgh to investigate the relationship between epigenetic aging and patient outcomes following severe traumatic brain injury (TBI). The key objectives are to: 1) Examine the link between accelerated epigenetic aging, measured through DNA methylation and epigenetic clock computations in cerebrospinal fluid samples, and...